3D MammographyAt Desert Imaging
How to Plan Mammography Exams Around COVID-19 Vaccines
Now that mass vaccinations against COVID-19 are underway, Desert Imaging has issued new guidance in accordance with the Society of Breast Imaging (SBI) on how to coordinate mammography exams for patients who plan to receive or have recently received a Covid-19 vaccine.
According to the SBI, “women with a recent COVID-19 vaccine may present for diagnostic workup for newly palpable axillary adenopathy or have new axillary adenopathy identified on routine screening mammography or ultrasound.” In other words, the lymph nodes located under the arm may enlarge on the side in which the vaccine was injected as a natural immune system response. The lymph nodes are part of the white blood cells or infection fighting system of the body. Vaccines of all types can result in temporary swelling of the lymph nodes, which may be a sign that the body is making antibodies in response as intended.
However, the detection of the enlarged lymph nodes may result in additional imaging to make sure everything is in order. To reduce the probability for additional imaging, Desert Imaging’s guidance to Mammography patients is as follows:
3D Digital Mammography
The Genius™ 3D Mammography™ exam, available on the Selenia® Dimensions® system from Hologic, is available at four Desert Imaging clinics across El Paso: (West) 122 W. Castellano Drive 79912. (East) 1727 Lee Trevino Drive 79936, (Far East) 3080 Joe Battle, and (Horizon City) 13650 Eastlake Blvd, Ste. A-102. This system is also featured aboard our mobile mammography clinic called MOM – Mammos on the Move. These systems expand Desert Imaging’s comprehensive commitment to promoting breast health in the region when coupled with our existing breast services including breast MRI, breast Ultrasound, breast biopsy, and breast elastography.
The Importance of the 3D Mammogram
Just Ask Sheryl Crow
What is Henda's Law & how does it affect my mammogram?
Frequently asked questions
Did you know?
The National Cancer Institute (NCI) adds that women who have had breast cancer and those who are at increased risk due to a genetic history of breast cancer should seek expert medical advice about whether they should begin screening before age 40 and about the frequency of screening.